Spring 2026 Co-op: Immunobiology Assay Development at Prime Medicine

Cambridge, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

B.S. candidate in Cell & Molecular Biology or related discipline
Basic knowledge of molecular biology, cell biology and biochemistry
Excellent troubleshooting and communication skills
Ability to work independently and within a team
Preferred Qualifications
Hands-on experience with aseptic cell culture of mammalian cells
Experience with tissue dissociation
Experience with flow cytometry
Familiarity with Excel and PowerPoint for data analysis
Independently motivated, detail-oriented, and excellent problem-solving abilities

Responsibilities

Processing tissues into single cell suspensions for use immunobiology assays
Aseptic culture of primary and immortalized mouse and human cells
Setting up, performing, and collecting and analyzing data for in vivo, ex vivo, and in vitro immunogenicity assays
Preparing cell samples for flow cytometry assays
Data analysis, interpretation, and presentations within the team

Skills

Cell Culture

Molecular Biology

Flow Cytometry

Immunogenicity Assays

Tissue Processing

Single Cell Suspensions

Gene Editing

Immunology

Prime Medicine

Gene editing technology for genetic diseases

About Prime Medicine

Prime Medicine focuses on gene editing, specifically using a technology called Prime Editing to make precise changes to DNA. This technology can identify and fix faulty DNA segments, which helps restore normal genetic function. The company aims to cure, halt, or prevent genetic diseases, providing long-term benefits to patients. Prime Medicine targets individuals with genetic disorders, a significant market globally. Unlike many competitors, it emphasizes collaboration with research institutions and pharmaceutical companies to advance its technology and bring it to market through licensing agreements and partnerships. The leadership team has extensive experience in developing innovative medicines, and the company is committed to enhancing its technological capabilities.

Cambridge, MassachusettsHeadquarters

2019Year Founded

$306.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Flexible Work Hours

Risks

Intellectual property disputes may lead to costly legal battles and delays.

The competitive landscape in gene editing is intensifying, challenging Prime Medicine's market position.

Reliance on partnerships exposes Prime Medicine to risks if collaborations don't meet expectations.

Differentiation

Prime Editing offers precise DNA modifications without double-stranded breaks, unlike CRISPR.

Prime Medicine's technology can correct faulty DNA segments, restoring normal genetic function.

The company collaborates with top-tier partners like Bristol Myers Squibb for strategic growth.

Upsides

Prime Medicine secured $244.6M to advance its genetic therapies and pipeline.

The partnership with Bristol Myers Squibb includes potential milestone payments over $3.5 billion.

Growing interest in gene editing for rare diseases boosts investment and collaboration opportunities.

Land your dream remote job 3x faster with AI

Try Jobo Free